Safety of interferon β-1a for treatment of COVID-19: a real-world study based on FAERS database

Journal Title: Shanghai Journal of Preventive Medicine - Year 2023, Vol 35, Issue 6

Abstract

ObjectiveTo systematically evaluate the safety of interferon β-1a for treatment of corona virus disease 2019 (COVID-19), and to provide references for interferon β-1a's clinical application.MethodsThis study was conducted with the database from US Food and Drug Administration adverse event reporting system (FAERS) from January 1, 2015 to March 31, 2021. Information component (IC) and reporting odds ratio (ROR) methods were applied for signal mining.ResultsA total of 463 700 records of COVID-19 were selected for analysis, and 45 positive drug adverse event signals were detected. Headache (IC025=1.09, ROR025=2.28), pyrexia (IC025=0.51, ROR025=1.51) and multiple sclerosis relapse (IC025=3.67, ROR025=14.71) were positive adverse events with higher frequency. Autoimmune disorder (IC025=4.42, ROR025=24.03), streptococcal infection (IC025=4.12, ROR025=19.82), and multiple sclerosis relapse (IC025=3.67, ROR025=14.71) were positive adverse events. Acute lung injury, cardio-respiratory arrest and metabolic acidosis were associated with a higher proportion and frequency of death.ConclusionThere are certain safety issues with interferon β-1a in the treatment of COVID-19, and some adverse events with high frequency and high death rate deserve further attention by medical staffs.

Authors and Affiliations

YANG Rongqing,GAO Yongqing,HU Fangyuan,ZHAI Yinghong,WANG Kuiling,LU Chang,HE Jia,ZHANG Haiying,

Keywords

Related Articles

Health risk assessment of inhalation exposure to metallic elements in PM2.5 in four cities of the Pearl River Delta in 2022

Objective To understand the characteristics of PM2.5 pollution in the air of Pearl River Delta city in Guangdong Province under the COVID-19 epidemic and the health risks of inhaling elements in PM2.5.Methods In 2022, 1...

Risk assessment of nosocomial infection in children's specialist hospitals based on semi-quantitative assessment

ObjectiveTo identify high-risk factors and high-risk process of nosocomial infection, and then take targeted prevention and control measures to improve nosocomial infection management.MethodsWe identified and determine...

Development and application of a specialized scale of occupational stressors for medical staff

ObjectiveTo develop a professional occupational stress scale for medical staff (CSSM) and test its reliability and validity, so as to provide a technical tool for the evaluation and management of medical staff occu...

Analysis of detection of acute respiratory infection in children under 12 years old in Pudong New Area, Shanghai from 2019 to 2023

Objective To investigate the impact of acute respiratory infections in children under 12 years old in Pudong New Area, Shanghai from 2019 to 2023.Methods Acute respiratory infection samples of children under 12 years ol...

Monitoring of foodborne pathogens in some ready-to-eat fruits and vegetables in Shanghai in 2021

ObjectiveThe contamination of foodborne pathogens in ready-to-eat fruits and vegetables in Shanghai was analyzed to provide a scientific basis for food safety, risk assessment and related supervision.MethodsFrom June t...

Download PDF file
  • EP ID EP742153
  • DOI -
  • Views 9
  • Downloads 0

How To Cite

YANG Rongqing, GAO Yongqing, HU Fangyuan, ZHAI Yinghong, WANG Kuiling, LU Chang, HE Jia, ZHANG Haiying, (2023). Safety of interferon β-1a for treatment of COVID-19: a real-world study based on FAERS database. Shanghai Journal of Preventive Medicine, 35(6), -. https://europub.co.uk/articles/-A-742153